PBYI earnings call for the period ending June 30, 2020.
News & Analysis: Puma Biotechnology
PBYI earnings call for the period ending March 31, 2020.
Investors piled into cancer stocks. Here's why.
Success in clinical trials doesn't guarantee success on the market.
If you can handle the uncertainty, these small-cap stocks can make you very wealthy.
The company's only drug product encountered significant obstacles to increasing its market share in 2019, but investors can see a potential path to growth.
PBYI earnings call for the period ending December 31, 2019.
These top growth stocks could dramatically improve your financial wellbeing.
Puma's shares are on fire today.
What's the deal with this battered breast cancer biotech and is it a good deal?